Ena Oru

400 citations
11 papers · 260 · 1 hit paper · h-index 6

Impact in

  • Hepatology top 5%
    • Hepatitis C virus research
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment
    • HIV, Drug Use, Sexual Risk

Papers in

Ena Oru

11 papers receiving 259 citations

Ena Oru's Hit Papers

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial 2025 · 43 citations
430Years since publication10203040

Peers

Ena Oru
Comparison fields: 5 of 35
  • Hepatology 122
  • Epidemiology 87
  • Biological Psychiatry 4
  • Cardiology and Cardiovascular Medicine 22
  • Physiology 17
Replace Weiyan Yu with:
Weiyan Yu China
Valeria Pace Palitti Italy
Galina V. Volynets Russia
AA Samaila Nigeria
Abdul Qadir Bhutta United States
María Del Barrio Azaceta Spain
Mariantonia Lai Italy
Melanie B. White United States
Maria‐Vasiliki Papageorgiou Greece
Ena Oru relative to Weiyan Yu China Weiyan Yu's profile →
Citations per field
00.5×5×10×15×20×24.5×
Weiyan Yu · 1×
Citations per year

Countries citing papers authored by Ena Oru

Since Specialization
Citations

This map shows the geographic impact of Ena Oru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ena Oru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ena Oru more than expected).

Fields of papers citing papers by Ena Oru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ena Oru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ena Oru. The network helps show where Ena Oru may publish in the future.

Co-authors

The 25 scholars most cited alongside Ena Oru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ena Oru Line = papers co-authored together Ena Oru links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 2021141
2
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
202543
3 202122
4 202517
5 202314
6 20198
7 20256
8 20234
9 20253
10 20191
11 20191

About Ena Oru

Ena Oru is a scholar working on Hepatology, Complementary and alternative medicine, Epidemiology, Physiology and Pharmacology, having authored 11 papers that have together received 260 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Alzheimer's disease research and treatments (3 papers), Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Medicinal Plants and Neuroprotection (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Pregnancy-related medical research (1 paper) and Injury Epidemiology and Prevention (1 paper). The work is most often cited by research in Hepatology (122 citations), Epidemiology (87 citations), Biological Psychiatry (4 citations), Cardiology and Cardiovascular Medicine (22 citations) and Physiology (17 citations). Ena Oru has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Philippa Easterbrook, Adam Trickey, Steve Kanters, Xiaosu Ma, Jeremiah Jones, Axel Haupt, Jennie Lenora Walgren, Daniel Gaudet, Giacomo Ruotolo and Stephen James Nicholls. Their work appears in journals such as Journal of Hepatology, The Lancet, Archives of Public Health, BJPsych Open and The Lancet Global Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact